Sivik Global Healthcare’s Boston Scientific BSX Stock Holding History

Sivik Global Healthcare’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.89M	Hold	62,000	–	–	2.95%	13
2026 Q1	$3.89M	Sell	62,000 -8,000	-11%	-$640K	2.95%	13
2025 Q4	$6.67M	Hold	70,000	–	–	1.94%	16
2025 Q3	$6.83M	Sell	70,000 -10,000	-13%	-$1.04M	1.99%	15
2025 Q2	$8.59M	Sell	80,000 -20,000	-20%	-$2.02M	2.34%	14
2025 Q1	$10.1M	Sell	100,000 -10,000	-9%	-$1.01M	5.45%	2
2024 Q4	$9.82M	Buy	110,000 +5,000	+5%	+$440K	5.17%	3
2024 Q3	$8.8M	Sell	105,000 -10,000	-9%	-$788K	3.73%	8
2024 Q2	$8.86M	Sell	115,000 -20,000	-15%	-$1.46M	3.18%	6
2024 Q1	$9.25M	Sell	135,000 -25,000	-16%	-$1.61M	2.17%	5
2023 Q4	$9.25M	Hold	160,000	–	–	3.86%	6
2023 Q3	$8.45M	Hold	160,000	–	–	4.27%	4
2023 Q2	$8.65M	Buy	160,000 +5,000	+3%	+$261K	2.02%	4
2023 Q1	$7.75M	Sell	155,000 -30,000	-16%	-$1.41M	3.33%	8
2022 Q4	$8.56M	Hold	185,000	–	–	4.03%	2
2022 Q3	$7.17M	Hold	185,000	–	–	3.98%	3
2022 Q2	$6.89M	Sell	185,000 -15,000	-8%	-$611K	3.92%	6
2022 Q1	$8.86M	Buy	200,000 +40,000	+25%	+$1.73M	3.66%	2
2021 Q4	$6.8M	Sell	160,000 -60,000	-27%	-$2.52M	2.91%	16
2021 Q3	$9.55M	Buy	220,000 +30,000	+16%	+$1.33M	2.28%	10
2021 Q2	$8.12M	Sell	190,000 -35,000	-16%	-$1.47M	1.59%	16
2021 Q1	$8.7M	Buy	225,000 +25,000	+13%	+$946K	3.17%	5
2020 Q4	$7.19M	Buy	200,000 +30,000	+18%	+$1.08M	2.93%	12
2020 Q3	$6.5M	Buy	+170,000	New	+$6.55M	2.79%	19
2020 Q2	–	Sell	-7,500	Closed	-$3.71M	–	53
2020 Q1	$3.71M	Sell	7,500 -167,500	-96%	-$6.54M	1.47%	31
2019 Q4	$7.91M	Sell	175,000 -25,000	-13%	-$1.05M	2.94%	9
2019 Q3	$8.14M	Hold	200,000	–	–	4.11%	1
2019 Q2	$8.6M	Sell	200,000 -25,000	-11%	-$962K	2.08%	3
2019 Q1	$8.64M	Buy	225,000 +5,000	+2%	+$191K	3.18%	3
2018 Q4	$7.78M	Sell	220,000 -15,000	-6%	-$544K	4.19%	2
2018 Q3	$9.05M	Sell	235,000 -25,000	-10%	-$873K	3.23%	2
2018 Q2	$8.5M	Buy	260,000 +85,000	+49%	+$2.56M	3.27%	1
2018 Q1	$4.78M	Sell	175,000 -15,000	-8%	-$408K	2.23%	16
2017 Q4	$4.71M	Sell	190,000 -70,000	-27%	-$1.93M	1.75%	24
2017 Q3	$7.58M	Buy	260,000 +20,000	+8%	+$552K	2.58%	11
2017 Q2	$6.65M	Buy	240,000 +40,000	+20%	+$1.06M	2.44%	12
2017 Q1	$4.97M	Buy	200,000 +25,000	+14%	+$608K	2.32%	15
2016 Q4	$3.79M	Sell	175,000 -25,000	-13%	-$545K	1.81%	25
2016 Q3	$4.76M	Sell	200,000 -100,000	-33%	-$2.39M	2.4%	21
2016 Q2	$7.01M	Hold	300,000	–	–	3.49%	2
2016 Q1	$5.64M	Hold	300,000	–	–	2.5%	12
2015 Q4	$5.53M	Buy	300,000 +150,000	+100%	+$2.69M	2.63%	9
2015 Q3	$2.46M	Sell	150,000 -122,900	-45%	-$2.1M	1.19%	32
2015 Q2	$4.83M	Sell	272,900 -27,100	-9%	-$484K	1.68%	21
2015 Q1	$5.33M	Buy	+300,000	New	+$4.74M	1.81%	20
2014 Q2	–	Sell	-176,950	Closed	-$2.39M	–	73
2014 Q1	$2.39M	Sell	176,950 -23,050	-12%	-$303K	1.49%	30
2013 Q4	$2.4M	Buy	+200,000	New	+$2.36M	1.71%	31

Other funds holding BSX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

FFM

Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

BPCE

Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return

Sivik Global Healthcare's BSX Position: Q2 2026 in Review

Sivik Global Healthcare held its Boston Scientific (BSX) position steady in Q2 2026 at 62,000 shares worth $3.89M. The position accounts for 2.95% of the portfolio, ranked #13.

Sivik Global Healthcare first reported a position in BSX in Q4 2013 and has held it in 47 quarters since. The position peaked at $10.1M in Q1 2025. 338 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Sivik Global Healthcare held 62,000 shares of Boston Scientific worth $3.89M as of Q2 2026.
Sivik Global Healthcare left its Boston Scientific share count unchanged in Q2 2026.
Boston Scientific made up 2.95% of Sivik Global Healthcare's portfolio in Q2 2026, its #13 holding.
Sivik Global Healthcare first reported a position in Boston Scientific in Q4 2013 and has held it in 47 quarters since.
Sivik Global Healthcare's Boston Scientific position peaked at $10.1M in Q1 2025.
338 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Sivik Global Healthcare's 13F filing for Q2 2026, filed 20 Jul 2026.